Bai GC, Mi Y, Song Y, Hao JR, He ZS, Jin J. Small bowel obstruction caused by secondary jejunal tumor from renal cell carcinoma: A case report. World J Clin Cases 2021; 9(19): 5339-5344 [PMID: 34307587 DOI: 10.12998/wjcc.v9.i19.5339]
Corresponding Author of This Article
Yi Song, PhD, Professor, Department of Urology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing 100034, China. ddsongyi@263.net
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jul 6, 2021; 9(19): 5339-5344 Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5339
Small bowel obstruction caused by secondary jejunal tumor from renal cell carcinoma: A case report
Gao-Chen Bai, Yue Mi, Yi Song, Jin-Rui Hao, Zhi-Song He, Jie Jin
Gao-Chen Bai, Yue Mi, Yi Song, Jin-Rui Hao, Zhi-Song He, Jie Jin, Department of Urology, Peking University First Hospital, Beijing 100034, China
Author contributions: Bai GC acquired the images, wrote the first draft of the manuscript, and submitted the manuscript; Mi Y and Hao JR collected and analyzed the data; He ZS and Jin J designed the study; Song Y critically revised the manuscript for important intellectual content; all authors have read and approved the manuscript for submission.
Informed consent statement: Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest related to this manuscript.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yi Song, PhD, Professor, Department of Urology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing 100034, China. ddsongyi@263.net
Received: March 8, 2021 Peer-review started: March 8, 2021 First decision: March 25, 2021 Revised: March 29, 2021 Accepted: April 25, 2021 Article in press: April 25, 2021 Published online: July 6, 2021 Processing time: 108 Days and 1.4 Hours
Abstract
BACKGROUND
Secondary jejunal tumor from renal cell carcinoma (RCC) is extremely rare in clinical practice and is easily missed and misdiagnosed because of the low incidence and atypical symptoms.
CASE SUMMARY
A 38-year-old male patient was diagnosed pathologically with left RCC after radical nephrectomy in 2012. The patient then suffered multiple lung metastases 2 years later and was treated with oral sorafenib without progression for 6 years. In 2020, an emergency intestinal segmental resection due to intestinal obstruction was required, and postoperative pathology confirmed a jejunal secondary tumor from RCC. The patient had a smooth recovery following surgery. Three months after surgery, the patient was diagnosed with left adrenal metastasis, and subsequent sintilimab therapy has stabilized his condition.
CONCLUSION
This report is written to remind urologists and pathologists of the potential for small intestinal secondary tumors when a patient with a history of RCC seeks treatment for digestive symptoms. Enteroscopy and abdominal contrast-enhanced computed tomography are essential means of examination, but severe cases require immediate surgical intervention despite the lack of a preoperative examination to distinguish tumor attributes.
Core Tip: Jejunal secondary tumor from renal cell carcinoma (RCC) is extremely rare. Herein, we present a case of small bowel obstruction caused by a jejunal secondary tumor from RCC. A male patient who underwent a left radical nephrectomy for RCC before visited the hospital with intestinal obstruction symptoms. Emergency intestinal segmental resection was performed, and postoperative pathology confirmed a jejunal secondary tumor from RCC. This report is written to remind urologists and pathologists of the potential for small intestinal secondary tumors when a patient with a history of RCC seeks treatment for digestive symptoms.
